SerpinA11 is a protein that can be activated through various biochemical mechanisms, particularly those involving the modulation of intracellular cyclic nucleotide levels. Activation of adenylyl cyclase, for instance, leads to an increase in cyclic adenosine monophosphate (cAMP) within the cell, a second messenger that plays a pivotal role in numerous signaling pathways. This elevation of cAMP is a crucial step in the functional activation of SerpinA11, as it is involved in the downstream signaling that governs SerpinA11's activity in the cell. Additionally, the inhibition of phosphodiesterases, which are responsible for the degradation of cAMP, results in sustained levels of this cyclic nucleotide, thereby providing a conducive environment for the persistent activation of SerpinA11. Such a rise in cAMP can be triggered by various agents, some of which act selectively on specific phosphodiesterase isoforms, ensuring that cAMP levels remain elevated, indirectly supporting the activation of SerpinA11.
Moreover, SerpinA11 activity can be indirectly influenced by agents that stimulate beta-adrenergic receptors, which are known to enhance the production of cAMP via G protein-coupled receptor signaling. These agonists effectively lead to the activation of SerpinA11 by initiating a cascade of events that culminate in increased cAMP and subsequent signaling events that SerpinA11 is a part of. Another pathway involves prostaglandins, which are capable of elevating cAMP levels in different tissue types, hinting at a broader spectrum of physiological contexts in which SerpinA11 can be activated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, leading to increased cAMP and potentially upregulating SerpinA11 activity via cAMP-mediated signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that stimulates cAMP production, which may lead to the activation of SerpinA11 through cAMP-dependent mechanisms. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibitor of phosphodiesterase type 5, resulting in increased cAMP and cGMP levels, which can enhance SerpinA11 activity through nucleotide signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective inhibitor of phosphodiesterase 4, increasing cAMP concentrations and possibly promoting SerpinA11 activity via cAMP-dependent processes. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Phosphodiesterase 3 inhibitor that increases cAMP levels, potentially enhancing SerpinA11 activity via cAMP-dependent signaling. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Phosphodiesterase 3 inhibitor, leading to elevated cAMP levels, which may upregulate SerpinA11 activity through cAMP-mediated signaling pathways. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Prostaglandin E1 analog that increases cAMP in various tissues, potentially activating SerpinA11 through cAMP-mediated pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 that can raise cAMP levels, which might lead to the activation of SerpinA11 through cAMP-dependent mechanisms. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Beta-adrenergic agonist that increases cAMP production, potentially leading to enhanced SerpinA11 activity through cAMP-mediated signaling. | ||||||